IPO Trending
VIJAYAEQ / NSE, BSEListed

Vijaya Diagnostic Centre Limited

Established in 1981, Vijaya Diagnostic Centre is a leading diagnostic chain in Southern India, offering comprehensive pathology and radiology services with around 740 routine tests, 870 specialized pathology tests, 220 basic radiology tests, and 320 advanced radiology tests, along with customized health and wellness packages. The company operates 80 diagnostic centers and 11 reference laboratories across 13 cities in Telangana, Andhra Pradesh, the National Capital Region, and Kolkata, with 96.2% of revenue coming from Hyderabad and nearby regions. In the year ended March 31, 2021, Vijaya Diagnostic Centre conducted approximately 6.20 million pathology tests and 0.89 million radiology tests for about 2.63 million customers, and all its laboratories hold NABL accreditation, with three centers also holding NABH accreditation.

₹522 - ₹531Open
Listed Price540.00
Listing Gain+1.69%
TimelineBookbuilding IPO
Open01 Sep 2021
Close03 Sep 2021
Allotment08 Sep 2021
Listing14 Sep 2021

Quota Reservation Portions

QIBPortion: 1,77,69,031 shares
49.79%
Nii (hni)Portion: 53,30,710 shares
14.94%
RetailPortion: 1,24,38,323 shares
34.85%
EmployeePortion: 1,50,000 shares
0.42%

Minimum Application Bracket Matrix

Retail1 lots / 28 shares
₹14,868
sHNI14 lots / 392 shares
₹2,08,152
bHNI68 lots / 1,904 shares
₹10,11,024

About the Company

Established in 1981, Vijaya Diagnostic Centre is a leading diagnostic chain in Southern India, offering comprehensive pathology and radiology services with around 740 routine tests, 870 specialized pathology tests, 220 basic radiology tests, and 320 advanced radiology tests, along with customized health and wellness packages. The company operates 80 diagnostic centers and 11 reference laboratories across 13 cities in Telangana, Andhra Pradesh, the National Capital Region, and Kolkata, with 96.2% of revenue coming from Hyderabad and nearby regions. In the year ended March 31, 2021, Vijaya Diagnostic Centre conducted approximately 6.20 million pathology tests and 0.89 million radiology tests for about 2.63 million customers, and all its laboratories hold NABL accreditation, with three centers also holding NABH accreditation.

Company Promoters

Dr. S. Surendranath Reddy